Paxman AB (PXMBF)

Overview

Paxman AB (publ) is a pioneering company founded in 1996, with its headquarters situated in Karlshamn, Sweden. It operates globally, focusing on the development and sale of its flagship Paxman scalp cooling system. This innovative system is designed to significantly reduce hair loss associated with chemotherapy treatments, a common and distressing side effect for many cancer patients. Paxman AB not only delivers its solutions to a wide range of cancer centers and hospitals around the world but also partners in research collaboration agreements, such as with the National University Hospital, Singapore, to develop advanced medical devices. Through its dedicated efforts and groundbreaking products, Paxman AB (publ) empowers cancer patients to retain their dignity and confidence during challenging times.

Products and Services

• Paxman Scalp Cooling System

At the heart of Paxman AB's product line is the Paxman Scalp Cooling System. This state-of-the-art system is ingeniously designed to prevent the hair loss commonly induced by chemotherapy treatments in cancer patients. Through the application of controlled cooling to the scalp, it reduces the temperature of the scalp and hence diminishes the amount of chemotherapy medication that reaches the hair follicles. This product has gained worldwide recognition for its effectiveness, becoming a much-valued solution in numerous cancer centers and hospitals globally.

• Research Collaboration

Paxman has also entered into a research collaboration agreement with the National University Hospital, Singapore. This partnership focuses on the development of a next-generation portable cooling and compression device. Through this venture, Paxman AB is at the forefront of innovation in medical technology, seeking to expand its product line and offer new solutions that alleviate the side effects of cancer treatments and improve the quality of life for patients undergoing such treatments.